 | Michael R. Sanders, John B. Kostis - Medical - 2007 - 234 pages
...37. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and...of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853. 38 UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive... | |
 | Carlo M. Rotella, Edoardo Mannucci, Barbara Cresci - Medical - 1999 - 232 pages
...539-542. UK Prospettive Diabetes Study Group (1998) Intensive blood glucose contro! with sulphonylureas or insulin compared with conventional treatment and...of complications in patients with type 2 diabetes (UKPDS 33). Lancet352: 837-853. UK Prospective Diabetes Study Group (1998) Effect of intensive blood... | |
 | David Levy - Medical - 1999 - 218 pages
...Kingdom Prospective Diabetes Study • UKPDS Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and...of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853. • UKPDS Group. Effect of intensive blood-glucose control with... | |
 | Craig Frances, Stephen Bent, Sanjay Saint - Medical - 1999 - 746 pages
...DM who are of reproductive KEY °ge References Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and...of complications in patients with type 2 diabetes (UKPDS33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352(9131): 837-853, 1998. The effect... | |
 | Allan Gaw, MD, PhD, Christopher J Packard, MRCPath, DSc, James Shepherd, MB, ChB, PhD, FRCPath, FRCP(Glasg) - Medical - 1999 - 232 pages
...6. UK Prospective Diabetes Study (UKDPS) Group, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and...complications in patients with type 2 diabetes, Lancet 1998; 352:837-53. 7. Pedersen TR, The Norwegian multicenter study of timolol after myocardial infarction,... | |
 | Francesco Belfiore, Carl Erik Mogensen - Medical - 2000 - 270 pages
...hypertension. N Engl J Med 1999;340:677-684. UKPDS Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and...of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998a;352:837-853. UKPDS Group: Tight blood pressure control and risk of macrovascular... | |
 | Dimitrios G. Oreopoulos, William R. Hazzard, Robert G. Luke - Medical - 2000 - 270 pages
...21. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and...of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853. 22. Sawicki PT, Didjurgeit U, Muhlhauser I, Bender R, Heinemann... | |
 | Paolo De Cristofaro - Cooking - 2002 - 304 pages
...diabetes (UKPDS 34). Lancet352: 854-865. 1998. UKPDS: intensive blood-glucose contrai with sulphonylureas or insulin compared with conventional treatment and...of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853, 1998. Zimmet P.Alberti KGMM, Shaw. Global and societal implications... | |
 | William T. Cefalu - Medical - 2000 - 776 pages
...280:1490-1496, 1998. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and...of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998. UK Prospective Diabetes Study Group. Effect of intensive blood... | |
 | Donna E. Shalala - Medical - 2000 - 612 pages
...of Medicine 329:304-309, 1993. 89 UKPDS Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and...of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998. 90 Reichard, P.; Pihl, M.; Rosenqvist, U.; et al. Complications... | |
| |
Group. Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). 
